Report generated from MPH Formulary provided by FormularyComplete ( Accessed Formulary Status. TA Number.

Size: px
Start display at page:

Download "Report generated from MPH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number."

Transcription

1 Report generated from MPH provided by Complete ( Accessed Title Status Section TA Number TA Link Alu-Cap simeticone->aluminium- and magnesium-containing antacids->aluminium HYDROXIDE->Aluminium-only Mucogel simeticone->aluminium- and magnesium-containing antacids->aluminium HYDROXIDE->Co-magaldrox MAGNESIUM TRISILICATE simeticone->aluminium- and magnesium-containing antacids Magnesium Trisilicate Mixture, BP simeticone->aluminium- and magnesium-containing antacids->magnesium TRISILICATE Infacol simeticone->simeticone alone Gaviscon reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Alginate raft-forming oral suspensions Gastrocote reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate

2 Gaviscon Advance Gaviscon Infant HYOSCINE BUTYLBROMIDE Buscopan PROPANTHELINE BROMIDE Pro-Banthine MEBEVERINE HYDROCHLORIDE Mebeverine Hydrochloride RANITIDINE Ranitidine Zantac reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate gut motility->antimuscarinics gut motility->antimuscarinics->hyoscine BUTYLBROMIDE gut motility->antimuscarinics gut motility->antimuscarinics->propantheline BROMIDE gut motility->other antispasmodics gut motility->other antispasmodics->mebeverine HYDROCHLORIDE protectants->1.3.1 H2-receptor antagonists protectants->1.3.1 H2-receptor antagonists->ranitidine protectants->1.3.1 H2-receptor antagonists->ranitidine TRIPOTASSIUM DICITRATOBISMUTHATE protectants->1.3.3 Chelates and complexes

3 De-Noltab SUCRALFATE Antepsin Prostaglandin analogues MISOPROSTOL Cytotec Proton pump inhibitors ESOMEPRAZOLE Esomeprazole LANSOPRAZOLE Lansoprazole Zoton OMEPRAZOLE Omeprazole protectants->1.3.3 Chelates and complexes->tripotassium DICITRATOBISMUTHATE protectants->1.3.3 Chelates and complexes protectants->1.3.3 Chelates and complexes->sucralfate protectants protectants->1.3.4 Prostaglandin analogues protectants->1.3.4 Prostaglandin analogues->misoprostol protectants inhibitors inhibitors->esomeprazole inhibitors inhibitors->lansoprazole inhibitors->lansoprazole inhibitors inhibitors->omeprazole

4 Losec PANTOPRAZOLE Pantoprazole CODEINE PHOSPHATE LOPERAMIDE HYDROCHLORIDE Loperamide Imodium BALSALAZIDE SODIUM Colazide MESALAZINE Mezavant XL Octasa Pentasa Salofalk Sulfasalazine Salazopyrin inhibitors->omeprazole inhibitors inhibitors->pantoprazole 1.4 Acute diarrhoea->1.4.2 Antimotility drugs 1.4 Acute diarrhoea->1.4.2 Antimotility drugs 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE Aminosalicylates Aminosalicylates->BALSALAZIDE SODIUM Aminosalicylates Aminosalicylates->MESALAZINE Aminosalicylates->MESALAZINE Aminosalicylates->MESALAZINE Aminosalicylates->MESALAZINE Aminosalicylates->SULFASALAZINE Aminosalicylates->SULFASALAZINE

5 BECLOMETASONE DIPROPIONATE Clipper BUDESONIDE Budenofalk HYDROCORTISONE Colifoam PREDNISOLONE Prednisolone Predsol AZATHIOPRINE CICLOSPORIN MERCAPTOPURINE Preparations METHOTREXATE Preparations No UK PL Corticosteroids Corticosteroids->BECLOMETASONE DIPROPIONATE Corticosteroids Corticosteroids->BUDESONIDE Corticosteroids Corticosteroids->HYDROCORTISONE Corticosteroids Corticosteroids->PREDNISOLONE->Rectal Corticosteroids->PREDNISOLONE->Rectal affecting the immune response affecting the immune response affecting the immune response affecting the immune response->mercaptopurine affecting the immune response affecting the immune response->methotrexate

6 ADALIMUMAB TA329 ADALIMUMAB TA187 INFLIXIMAB TA329 INFLIXIMAB TA187 INFLIXIMAB TA163 GOLIMUMAB TA329 VEDOLIZUMAB affecting the immune response->vedolizumab TA352 Entyvio affecting the immune response->vedolizumab->vedolizumab ISPAGHULA HUSK 1.6 Laxatives->1.6.1 Bulk-forming laxatives Fybogel 1.6 Laxatives->1.6.1 Bulk-forming laxatives->ispaghula HUSK BISACODYL laxatives Bisacodyl laxatives->bisacodyl DANTRON laxatives Co-danthramer laxatives->dantron->with poloxamer 188 (as co-danthramer)

7 Co-danthrusate DOCUSATE SODIUM Dioctyl Docusol GLYCEROL Glycerol Suppositories, BP SENNA Senna Senokot SODIUM PICOSULFATE Sodium Picosulfate ARACHIS OIL LACTULOSE Lactulose MACROGOLS Macrogol Oral Powder, Compound laxatives->dantron->with docusate sodium (as co-danthrusate) laxatives laxatives->docusate SODIUM laxatives->docusate SODIUM laxatives laxatives->glycerol laxatives laxatives->senna laxatives->senna laxatives laxatives->sodium PICOSULFATE 1.6 Laxatives->1.6.3 Faecal softeners laxatives laxatives->lactulose laxatives laxatives->macrogols

8 Movicol -Half Movicol Paediatric MAGNESIUM SALTS Magnesium hydroxide Magnesium Hydroxide Mixture, BP PHOSPHATES (RECTAL) Fleet Ready-to-use Enema SODIUM CITRATE (RECTAL) Micolette Micro-enema Relaxit Micro-enema MACROGOLS Klean-Prep Moviprep PHOSPHATES (ORAL) Fleet Phospho-soda SODIUM PICOSULFATE WITH MAGNESIUM CITRATE laxatives->macrogols laxatives->macrogols laxatives laxatives->magnesium SALTS laxatives->magnesium SALTS->Magnesium hydroxide laxatives laxatives->phosphates (RECTAL) laxatives laxatives->sodium CITRATE (RECTAL) laxatives->sodium CITRATE (RECTAL) ->MACROGOLS ->MACROGOLS ->PHOSPHATES (ORAL)

9 Picolax ->SODIUM PICOSULFATE WITH MAGNESIUM CITRATE METHYLNALTREXONE BROMIDE 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists Relistor 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists->methylnaltrexone BROMIDE LINACLOTIDE constipation Constella constipation->linaclotide LUBIPROSTONE constipation TA318 Amitiza constipation->lubiprostone PRUCALOPRIDE constipation TA211 Resolor constipation->prucalopride Scheriproct 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids Uniroid-HC 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids PHENOL 1.7 Local for anal and rectal disorders->1.7.3 Rectal sclerosants Oily Phenol Injection, BP 1.7 Local for anal and rectal disorders->1.7.3 Rectal sclerosants->phenol GLYCERYL TRINITRATE 1.7 Local for anal and rectal disorders->1.7.4 Management of anal fissures

10 Rectogesic URSODEOXYCHOLIC ACID Ursodeoxycholic Acid Ursofalk Ursogal COLESTYRAMINE PANCREATIN Creon Creon Micro Pancrex Pancrex V Creon Local for anal and rectal disorders->1.7.4 Management of anal fissures->glyceryl TRINITRATE secretions->1.9.1 Drugs affecting biliary composition and flow secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID secretions->1.9.2 Bile acid sequestrants secretions->1.9.4 Pancreatin secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength

11 Creon Methotrexate DILTIAZEM Sucralfate Local formulary (non-bnf) Anusol Wind-eze peppermint chewable tablets No UK PL secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength 1.5 Chronic bowel disorders->inflammatory bowel disease 1.7 Local for anal and rectal disorders->1.7.4 Management of anal fissures 1.5 Chronic bowel disorders->inflammatory bowel disease 1.7 Local for anal and rectal disorders->1.7.1 Soothing haemorrhoidal simeticone->antacid containing simeticone

1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone

1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone Report generated from BNF - Local Information provided by FormularyComplete (www.pharmpress.com). Accessed 28 07 2017 Title Formulary Status Section Acidex 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2

More information

Report generated from Joint Formulary provided by FormularyComplete (www.pharmpress.com). Accessed TA Number

Report generated from Joint Formulary provided by FormularyComplete (www.pharmpress.com). Accessed TA Number Report generated from Joint Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 06 04 2017 Title Formulary Status Section TA Number TA Link Annotation ALUMINIUM HYDROXIDE Aluminium-only

More information

GASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease

GASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease Original Date of issue: 05/04/07 Last eviewed: 08/03/2013 Version: 5 Page 1 of 11 GASTO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease 1.1.1 Antacids and simeticone Magnesium Trisilicate

More information

Chapter 1 Gastro-Intestinal System

Chapter 1 Gastro-Intestinal System Chapter 1 page number 1 Chapter 1 Gastro-Intestinal System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

Chapter 1 Gastro-Intestinal System

Chapter 1 Gastro-Intestinal System Chapter 1 page number 1 Chapter 1 Gastro-Intestinal System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

BNF CHAPTER 1: GASTROINTESTINAL

BNF CHAPTER 1: GASTROINTESTINAL BNF CHAPTER 1: GASTROINTESTINAL 1.1 DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE For symptomatic relief of hyperacidity, peptic ulcers, oesophagitis and acid reflux, liquids usually act faster than

More information

1. Gastro-intestinal system

1. Gastro-intestinal system 1. Gastro-intestinal system Also see Appendix 1B Guidance on Management of Dyspepsia http://www.fifeadtc.scot.nhs.uk/formulary/1-gastro-intestinal/appendix-1b-management-ofdyspepsia.aspx Also see SIGN

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13 BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 BNF 1.1 ANTACIDS Mucogel and Peptac are effective antacids and are available over the counter Gaviscon / Gaviscon Advance are available over the counter First

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 ANTACIDS Maalox and Peptac are effective antacids that can be bought Over the Counter for self-limiting symptoms. Choice Product Cost Effective Options &Comments

More information

Gastrointestinal system

Gastrointestinal system Gastrointestinal system Medicines Formulary Contents: 1. Dyspepsia and gastro-oesophageal disease 1 2. Acute gastrointestinal bleeding 2 3. Irritable bowel syndrome 3 4. Diarrhoea 3 5. Inflammatory bowel

More information

1 Gastro-intestinal system

1 Gastro-intestinal system Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

Sandwell and West Birmingham Hospitals NHS Trust

Sandwell and West Birmingham Hospitals NHS Trust Sandwell and West Birmingham Hospitals NHS Trust Sandwell and West Birmingham Clinical Commissioning Group The drugs contained in the formulary of Sandwell and West Birmingham Hospitals Trust are listed

More information

1 Gastro-intestinal system

1 Gastro-intestinal system Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

BNF/BNFC Chapter 1 Gastro-intestinal System

BNF/BNFC Chapter 1 Gastro-intestinal System NF/NF hapter 1 Gastro-intestinal System irections for questions 1 to 10. ach of the questions or incomplete statements in this section is followed by five suggested answers. Select the best answer in each

More information

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic laxatives Hawler medical university Collage of pharmacy/ fourth stage /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER European Medicines Agency Evaluation of Medicines for Human Use London, October 2007 Doc. Ref. EMEA/527934/2007 ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER The Paediatric Working Party

More information

Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area

Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Prescribing Committee formulary decisions Prepared by Pharmicus

More information

Constipation. What is constipation? What causes constipation? How common is constipation?

Constipation. What is constipation? What causes constipation? How common is constipation? Constipation What is constipation? Constipation is the word we use to describe any difficulty having a bowel movement. This does not just mean infrequent bowel movements, (two or fewer bowel movements

More information

Gateshead Formulary. Adapted with thanks from Formulary document prepared by Pharmicus

Gateshead Formulary. Adapted with thanks from Formulary document prepared by Pharmicus Gateshead Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Prescribing Committee formulary decisions Adapted with thanks from Formulary

More information

Care at the Chemist. Formulary

Care at the Chemist. Formulary Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) For ages 2 years and over. Chloramphenicol 1% eye oint. (4g) For ages 2 years and over. Allergy Loratadine

More information

Care at the Chemist. Formulary

Care at the Chemist. Formulary Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) Chloramphenicol 1% eye oint. (4g) Allergy Loratadine 10mg tablets (7) Sodium cromoglycate 2% eye drops

More information

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea. Antacids Hawler medical university Collage of pharmacy/ fourth year /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information

Second term/

Second term/ Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic

More information

3.4 gram/7 gram powder -- $5.63

3.4 gram/7 gram powder -- $5.63 MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Bowel Movements P&T DATE: 9/11/2018 CLASS: Gastrointestinal Disorders REVIEW HISTORY: 12/16, 9/15, 9/12, 5/08 LOB: MCL (MONTH/YEAR)

More information

Constipation an Old Friend. Presented by Dr. Keith Harris

Constipation an Old Friend. Presented by Dr. Keith Harris Constipation an Old Friend Presented by Dr. Keith Harris Irregularity and the Tricks of the Trade." CONSTIPATION What is constipation? INFREQUENT BOWEL MOVEMENTS DIFFICULTY DURING DEFECATION SENSATION

More information

Examples of prices, license restrictions and availability of common over the counter medications.

Examples of prices, license restrictions and availability of common over the counter medications. Examples of s, license restrictions and availability of common over the counter medications. GSL items can be purchased from any er. Supermarkets and discount stores may be more cost effective than pharmacies.

More information

MCA Training Made Easy

MCA Training Made Easy MCA Training Made Easy MODULE 8 Indigestion and Bowel Problems Learning objectives After reading this module you will: Understand the symptoms and causes of indigestion and heartburn and how to treat them

More information

Laxative Policy THIS POLICY MUST BE READILY ACCESSIBLE AT ALL TIMES AND AT THE POINT WHERE MEDICINES ARE USED.

Laxative Policy THIS POLICY MUST BE READILY ACCESSIBLE AT ALL TIMES AND AT THE POINT WHERE MEDICINES ARE USED. Laxative Policy This is a working document and any changes that become necessary to this policy must be notified in writing to the Medicine Management Group via the Chief Pharmacist, East Cheshire Trust

More information

Guidelines for the Management of Constipation: Adult Patients

Guidelines for the Management of Constipation: Adult Patients Guidelines for the Management of Constipation: Adult Patients This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances

More information

Doncaster & Bassetlaw Medicines Formulary

Doncaster & Bassetlaw Medicines Formulary Doncaster & Bassetlaw Medicines Formulary Section 1.5 Chronic Bowel Disorders (including IBD) Aminosalicylates: Mesalazine 400mg and 800mg MR Tablets (Octasa) Mesalazine 1.2g MR Tablets (Mezavant XL) Mesalazine

More information

Primary Care Constipation Guidelines. Version 1 November 2016

Primary Care Constipation Guidelines. Version 1 November 2016 Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and

More information

Antidiarrheals Antidiarrheal

Antidiarrheals Antidiarrheal Antidiarrheals Major factors in diarrhea Increased motility of the GI tract. Decreased absorption of fluid. Antidiarrheal drugs include: Antimotility agents. Adsorbents. Drugs that modify fluid and electrolyte

More information

.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch.

.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch. .Drugs and the gastrointestinal system Chapter 11 11.1 Gastric acid-related conditions 149 11.2 Nausea and vomiting 153 11.3 Disorders of the bowel 155 11.4 Gallstones 156 Self-assessment on Chapter 11:

More information

SELF CARE AND OTC MEDICINES ON PRESCRIPTION

SELF CARE AND OTC MEDICINES ON PRESCRIPTION 306 Medical Centre: SELF CARE AND OTC MEDICINES ON PRESCRIPTION NHS Southwark CCG no longer supports the routine prescribing on the NHS of medications for short term illnesses and minor conditions and

More information

Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed

Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 24 11 2017 This is a live document. Changes may have been made to the formulary since this report

More information

ABC of palliative care: Constipation and diarrhoea

ABC of palliative care: Constipation and diarrhoea BMJ 1997;315:1293-1296 (15 November) Clinical review ABC of palliative care: Constipation and diarrhoea Marie Fallon, Bill O'Neill Prevalence of constipation Top Prevalence of constipation Assessment of

More information

Opioid constipation treatment dulcolax

Opioid constipation treatment dulcolax P ford residence southampton, ny Opioid constipation treatment dulcolax Posts about how to relieve constipation instantly written by gbrese1958. Official Web site for MOVANTIK (naloxegol) tablets, for

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v15 02.04.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

Managing constipation in adults with co-morbidities

Managing constipation in adults with co-morbidities Managing constipation in adults with co-morbidities Angela Gardiner and Andrea Hilton Constipation can be described in a number of ways but in general it is related to straining, reduced frequency of defecation

More information

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE Definition A circumscribed ulceration of the gastrointestinal mucosa occurring in areas exposed to acid and pepsin and most often caused

More information

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer. Pharmacology - Problem Drill 21: Drugs Used To Treat GI Disorders No. 1 of 10 1. Endogenous secretagogues for stomach acid include: #01 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Histamine

More information

Cambridgeshire Community Pharmacy Minor Ailments Service. February 2009

Cambridgeshire Community Pharmacy Minor Ailments Service. February 2009 Cambridgeshire Community Pharmacy Minor Ailments Service February 2009 Contents 3 Constipation & Paediatric Constipation 4 Diarrhoea & Paediatric Diarrhoea 5 Indigestion & Infant Gripes/Colic/Wind 6 Hay

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v14 05.02.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

Pharmacology. Drugs that Affect the Gastrointestinal System

Pharmacology. Drugs that Affect the Gastrointestinal System Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v19 19.11.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

The management of constipation in adults

The management of constipation in adults The management of constipation in adults Angela Gardiner and Andrea Hilton Abstract Definitions of constipation vary, but in general are related to straining at stool, reduced frequency of defecation and/or

More information

Protocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians.

Protocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. NY&AWC Medicines Management Team Protocol to support reducing the use of and the effective use of laxatives Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols

More information

Frequently Asked Questions Specific Medications

Frequently Asked Questions Specific Medications Medications to control inflammation are the single most important means of treating IBD. By bringing the inflammation under control, medications can relieve the symptoms of IBD and reduce the chances of

More information

Gastro-intestinal System

Gastro-intestinal System CHAPTER 1 GASTRO-INTESTINAL SYSTEM 1.1 Nil by mouth patients drug administration Patients for investigations e.g. OGD (endoscopy): administer usual medicines with a sip of water caution with medicines

More information

daily; available as 10- mg g PO

daily; available as 10- mg g PO Overview of the PRN: The Pain and Palliative Care PRN of ACCP is an organization of pharmacy practitioners, clinical scientists, pharmacy educators, and others. Its mission is to advance pain and palliative

More information

Formulary. 12 th Edition. Version14.1. May Eleanore Atkinson Medicines Information Pharmacist. Drug and Therapeutics Committee

Formulary. 12 th Edition. Version14.1. May Eleanore Atkinson Medicines Information Pharmacist. Drug and Therapeutics Committee Drug and Therapeutics Committee Formulary 12 th Edition Version14.1 May 2015 Compiled on behalf of the Drug and Therapeutics Committee by Eleanore Atkinson Medicines Information Pharmacist Formulary 12

More information

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Erin Zimny, MD Emergency Medicine Hospice and Palliative Medicine Henry Ford Hospital Disclosures I do NOT have any financial

More information

Lab:2 Drugs acting on Gastrointestinal tract

Lab:2 Drugs acting on Gastrointestinal tract Lab:2 Drugs acting on Gastrointestinal tract Drugs that used to treat three common medical conditions involving the gastrointestinal tract: peptic ulcers and gastroesophageal reflux disease (GERD), chemotherapy-induced

More information

This is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format.

This is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format. This is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format. Part or all of this document may be printed from this file and distributed

More information

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club Efficacy and Safety of Lubiprostone Laura Wozniak February 23, 2010 K30 Monthly Journal Club Objectives Brief overview of constipation Review of article Discussion Constipation in Children 3-5% of all

More information

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve Treat primary symptoms Background information for clinicians Offer general lifestyle advice Background information for patients Manage IBS according to the dominant symptom Provenance Psychological symptoms

More information

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:

More information

Crohn s Disease. How does Crohn s disease affect the intestinal tract?

Crohn s Disease. How does Crohn s disease affect the intestinal tract? Crohn s Disease Crohn s disease is one of the two main forms of inflammatory bowel disease (IBD). The second main form of inflammatory bowel disease is ulcerative colitis. Crohn s disease causes inflammation

More information

Opioid-induced constipation a preventable problem

Opioid-induced constipation a preventable problem www.veteransmates.net.au Opioid-induced a preventable problem One of the most common adverse effects of chronic opioid therapy is. 1-4 Up to 95% of patients prescribed an opioid report as a side effect,

More information

Local Minor Ailment Service Formulary

Local Minor Ailment Service Formulary Local Minor Ailment Service Formulary August 2009 COPYRIGHT 2009 GREATER GLASGOW AND CLYDE NHS BOARD ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED, STORED IN A RETRIEVAL SYSTEM, OR

More information

National Institute for Health and Care Excellence

National Institute for Health and Care Excellence National Institute for Health and Care Excellence 4-year surveillance (2017) Ulcerative colitis: management (2013) NICE guideline CG166 Appendix A.2: Summary of new evidence from surveillance Patient information

More information

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August BRAND NAME Symproic GENERIC NAME Naldemedine MANUFACTURER Shionogi Inc. DATE OF APPROVAL March 23, 2017 PRODUCT LAUNCH DATE Anticipated to launch mid-summer 2017 REVIEW TYPE Review type 1 (RT1): New Drug

More information

Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) Irritable Bowel Syndrome (IBS) Dr Rex J Polson 17 th January 2018 Overview Description of the condition Discussion of symptoms and investigations that may be required Discussion of management and treatment

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v28 23.04.2018) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v20 23.2.2016) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

Medical therapies and IBD

Medical therapies and IBD Medical therapies and IBD Although there is no cure for IBD, there are many treatment options available. There is no standard treatment for IBD that is effective in all situations or for all patients,

More information

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest)

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest) EMA workshop on the development of new medicinal products for the treatment of ulcerative colitis and Crohn s disease Overview of authorised medicines for IBD in Europe - previous regulatory positions

More information

Bowel Management, Community Nursing

Bowel Management, Community Nursing CLINICAL GUIDELINE Bowel Management, Community Nursing A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on

More information

Gastrointestinal Pharmacology

Gastrointestinal Pharmacology Gastrointestinal Pharmacology Jan Kehr Department of Physiology and Pharmacology Gastrointestinal Pharmacology v Background v Peptic disorders v Constipation and Diarrhea v Chronic Bowel Disease Gastrointestinal

More information

Chapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given

Chapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given Chapter 5 Gastroenterology Georgia Woodfield TERLIPRESSIN CIPROFLOXACIN 2 initial dose 500 Every 4 hours until bleeding controlled can be reduced to 1 after initial dose if side effects develop or if patient

More information

Local Minor Ailment Service Formulary

Local Minor Ailment Service Formulary Local Minor Ailment Service Formulary January 2013 COPYRIGHT 2013 GREATER GLASGOW AND CLYDE NHS BOARD ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED, STORED IN A RETRIEVAL SYSTEM, OR

More information

What Is Constipation?

What Is Constipation? CONSTIPATION What Is Constipation? Constipation is when you have infrequent or hard-to-pass bowel movements (meaning they are painful or you have to strain), have hard stools or feel like your bowel movements

More information

Pharmacy Services. The Forth Valley Minor Ailments Service Formulary. 2 nd edition

Pharmacy Services. The Forth Valley Minor Ailments Service Formulary. 2 nd edition Pharmacy Services The Forth Valley Minor Ailments Service Formulary 2 nd edition December 2007 1 Contents Contact numbers 2 Introduction 3 How to use this formulary Acknowledgements Section 5 Skin 12 Acne

More information

Gastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD

Gastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD Formulary Book : Contents Subparagraph Page Nbr. 1.1.2.1 Gastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD 1.2 Gastro-intestinal system Antispasmod.&Other

More information

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital New treatment options in UC Rob Bryant IBD Consultant Royal Adelaide Hospital Talk Outline 1. Raising expectations 2. Optimising UC therapy 3. Clinical trials 4. What s new on the PBS? 5. Questions 1.

More information

Local Minor Ailment Service Formulary

Local Minor Ailment Service Formulary Local Minor Ailment Service Formulary Pharmacy and Prescribing Team Revised 2013 Reference: MAS Version 1 Supersedes: None Page 1 of 17 Date approved: 25 th October 2013 Review date: October 2016 Contents

More information

Joint Formulary. North Sefton & West Lancashire Area Medicines Management Committee. Sefton. Southport & Ormskirk Hospital NHS Trust

Joint Formulary. North Sefton & West Lancashire Area Medicines Management Committee. Sefton. Southport & Ormskirk Hospital NHS Trust Joint Formulary North Sefton & West Lancashire Area Medicines Management Committee Southport & Ormskirk Hospital NHS Trust Sefton Primary Care Trust Sefton Central Lancashire 2009 Contents Page Introduction

More information

NHS GRAMPIAN RESOURCE PACK BOWEL MANAGEMENT

NHS GRAMPIAN RESOURCE PACK BOWEL MANAGEMENT NHS GRAMPIAN RESOURCE PACK ON BOWEL MANAGEMENT Continence Advisory Service NHS Grampian January 2006 Date of review January 2008 NHS GRAMPIAN RESOURCE PACK ON BOWEL MANAGEMENT CONTENTS SECTION 1 - (Pages

More information

TA Number. TA Link. Annotation

TA Number. TA Link. Annotation Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation Anti-infective preparations Anti-inflammatory

More information

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

More information

Methadone Maintenance: safe and effective opioid pharmacotherapy. Karen Miotto, MD UCLA Department of Psychiatry

Methadone Maintenance: safe and effective opioid pharmacotherapy. Karen Miotto, MD UCLA Department of Psychiatry Methadone Maintenance: safe and effective opioid pharmacotherapy Karen Miotto, MD UCLA Department of Psychiatry Opioid abuse and dependence statistics, 2007 Persons who reported abuse or dependence in

More information

Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017

Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017 Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017 Subject: Presented By: Submitted To: Purpose of Paper: Self-care for Self-Limiting Conditions Policy Karen Watts, Director of Quality

More information

Infliximab (Remicade) for paediatric ulcerative colitis - second line

Infliximab (Remicade) for paediatric ulcerative colitis - second line Infliximab (Remicade) for paediatric ulcerative colitis - second line September 2011 This technology summary is based on information available at the time of research and a limited literature search. It

More information

Inflammatory bowel disease. Kawa Obeid, PhD

Inflammatory bowel disease. Kawa Obeid, PhD Inflammatory bowel disease Kawa Obeid, PhD 63 Introduction Inflammatory bowel disease (IBD) can be divided into two chronic inflammatory disorders of the gastro- intestinal tract, namely Crohn's disease

More information

Amitiza. Amitiza (lubiprostone) Description

Amitiza. Amitiza (lubiprostone) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.22 Subject: Amitiza Page: 1 of 5 Last Review Date: March 16, 2018 Amitiza Description Amitiza (lubiprostone)

More information

FOOT OFF THE BRAKES. Kerri Novak MD MSc FRCPC. Chronic Constipation: Taking the Foot off the Brakes Dr. Kerri Novak

FOOT OFF THE BRAKES. Kerri Novak MD MSc FRCPC. Chronic Constipation: Taking the Foot off the Brakes Dr. Kerri Novak CHRONIC CONSTIPATION: TAKING THE FOOT OFF THE BRAKES Kerri Novak MD MSc FRCPC www.seacourses.com 1 OUTLINE Epidemiology i Quality of life Approach Therapies www.seacourses.com 2 DEFINING CHRONIC CONSTIPATION

More information

Current management options and recent advances in IBD

Current management options and recent advances in IBD n DRUG REVIEW Current management options and recent advances in IBD Ben Warner BSc, MRCP and Peter Irving MA, MD, FRCP SPL The advent of biological therapies has revolutionised the management of inflammatory

More information

Kingston Hospital NHS FoundationTrust and Kingston CCG. Joint Medicines Formulary

Kingston Hospital NHS FoundationTrust and Kingston CCG. Joint Medicines Formulary Kingston Hospital NHS FoundationTrust and Kingston CCG Joint Medicines Formulary Published Version 3 November 2013 Approved by Kingston CCG Medicines Management Committee Kingston Hospital NHS FoundationTrust

More information

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 South East London Area Prescribing Committee: Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 Developed by: South East London IBD Pathway Development Group Approved: February

More information

A guide to Anoplasty (anal surgery)

A guide to Anoplasty (anal surgery) Saint Mary s Hospital Newborn Intensive Care Unit Information for Parents A guide to Anoplasty (anal surgery) Introduction This information leaflet is designed to help parents and families to care for

More information

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many

More information

COMMONLY USED DRUGS AND DOSES

COMMONLY USED DRUGS AND DOSES COMMONLY USED DRUGS AND DOSES Drug and formulation Indication Route, and frequency Ceiling Amitriptyline Endep Tablets: 10mg, 25mg, 50mg Neuropathic pain May assist sleep 0.2 1mg/kg/ Nocte (Can also be

More information

MEDICAL TERMS USED IN IBD

MEDICAL TERMS USED IN IBD INFORMATION SHEET MEDICAL TERMS USED IN IBD INTRODUCTION You are likely to come across many new terms when you are diagnosed with Inflammatory. Bowel Disease. This information sheet explains some of the

More information

Irritable Bowel Disease. Dr. Alexandra Ilnyckyj MD

Irritable Bowel Disease. Dr. Alexandra Ilnyckyj MD Irritable Bowel Disease Dr. Alexandra Ilnyckyj MD Exactly what is IBS? Common condition affecting mostly women Symptoms are variable but they reflect altered gut movement (motility) and sensation Commonly

More information

MAS Formulary Products

MAS Formulary Products Ibuprofen Susp.100mg/5ml for pain and inflammation 100ml Care Ibuprofen Tabs 200mg for pain and inflammation 24 Care ( Added Jan 2016) Ibuprofen Tabs 400mg for pain and inflammation 24 Tariff price - P

More information

Self care with over the counter products.

Self care with over the counter products. Self care with over the counter products www.lambethccg.nhs.uk What is self care? Self care is about looking after yourself in a healthy way. It can be anything from brushing your teeth, doing some exercise,

More information

Exclusion Criteria. Required Medical Documentation. Specified reasons for denial (if any), other than not meeting criteria requirements.

Exclusion Criteria. Required Medical Documentation. Specified reasons for denial (if any), other than not meeting criteria requirements. Partnership HealthPlan of California: New and Revised, 3nd Quarter P & T 2016 Effective 10/1/2016 Generic substitution required when there is an FDA approved generic equivalent; additional criteria apply

More information